Sorrento Therapeutics Inc

NASDAQ:SRNE   3:59:54 PM EDT
6.90
+0.12 (+1.77%)
4:39:31 PM EDT: $6.92 +0.02 (+0.29%)
Products

Sorrento Announces FDA IND Filing For COVI-AMG Neutralizing And High Potency Antibody Against SARS-COV-2

Published: 11/09/2020 14:36 GMT
Sorrento Therapeutics Inc (SRNE) - Sorrento Announces FDA Ind Filing Today for Covi-amg Neutralizing and High Potency Antibody Against Sars-cov-2.
Sorrento Therapeutics Inc - Animal Model Data Demonstrated a Highly Effective Neutralizing Profile.
Sorrento Therapeutics Inc - Initiated Cgmp Manufacturing to Produce 100,000 Doses, Expected to Be Available Early Next Year.